|
🐜
|
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
10 auth.
H. C. Stary,
A. Chandler,
S. Glagov,
J. Guyton,
W. Insull,
M. Rosenfeld,
...
S. A. Schaffer,
C. Schwartz,
W. Wagner,
R. Wissler
|
10 |
1994 |
10
🐜
|
|
🐜
|
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
10 auth.
H. C. Stary,
A. Chandler,
S. Glagov,
J. Guyton,
W. Insull,
M. Rosenfeld,
...
S. A. Schaffer,
C. Schwartz,
W. Wagner,
R. Wissler
|
10 |
1994 |
10
🐜
|
|
🐜
|
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, P
15 auth.
L. Goldstein,
R. Adams,
M. Alberts,
L. Appel,
L. Brass,
C. Bushnell,
A. Culebras,
T. DeGraba,
P. Gorelick,
J. Guyton,
...
R. Hart,
G. Howard,
M. Kelly‐Hayes,
J. V. I. Nixon,
R. Sacco
|
9 |
2006 |
9
🐜
|
|
🐬
|
A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia
W. Yancy,
M. Olsen,
J. Guyton,
R. Bakst,
E. Westman
|
9 |
2004 |
9
🐬
|
|
🐜
|
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
10 auth.
H. C. Stary,
A. Chandler,
S. Glagov,
J. Guyton,
W. Insull,
M. Rosenfeld,
...
S. A. Schaffer,
C. Schwartz,
W. Wagner,
R. Wissler
|
9 |
1994 |
9
🐜
|
|
🐢
|
Metabolic syndrome: definition, pathophysiology, and mechanisms.
Phillippa J. Miranda,
R. DeFronzo,
R. Califf,
J. Guyton
|
8 |
2005 |
8
🐢
|
|
🦁
|
Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulant Heparin
J. Guyton,
R. Rosenberg,
A. Clowes,
M. Karnovsky
|
8 |
1980 |
8
🦁
|
|
🐢
|
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
J. Mckenney,
M. Davidson,
T. Jacobson,
J. Guyton
|
8 |
2006 |
8
🐢
|
|
🐜
|
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.
13 auth.
P. Moriarty,
P. Thompson,
C. Cannon,
J. Guyton,
J. Bergeron,
F. Zieve,
E. Bruckert,
T. Jacobson,
S. Kopecky,
M. Baccara-Dinet,
...
Yunling Du,
R. Pordy,
D. Gipe
|
8 |
2015 |
8
🐜
|
|
🦁
|
Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B
J. Guyton,
G. Dahlén,
W. Patsch,
J. Kautz,
A. Gotto
|
8 |
1985 |
8
🦁
|
|
🦁
|
Safety considerations with niacin therapy.
J. Guyton,
H. Bays
|
8 |
2007 |
8
🦁
|
|
🐜
|
Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation.
10 auth.
Gary L. Cushing,
J. Gaubatz,
Mauro L. Nava,
B. Burdick,
T. Bocan,
J. Guyton,
...
D. Weilbaecher,
M. Debakey,
G. Lawrie,
J. Morrisett
|
7 |
1989 |
7
🐜
|
|
🐜
|
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study.
7 auth.
D. Capuzzi,
J. Guyton,
J. Morgan,
A. Goldberg,
R. Kreisberg,
O. Brusco,
...
J. Brody
|
7 |
1998 |
7
🐜
|
